Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients.
Authors
Ahuja, S DAshkin, D
Avendano, M
Banerjee, R
Bauer, M
Bayona, J N
Becerra, M C
Benedetti, A
Burgos, M
Centis, R
Chan, E D
Chiang, C-Y
Cox, H
D'Ambrosio, L
DeRiemer, K
Dung, N H
Enarson, D
Falzon, D
Flanagan, K
Flood, J
Garcia-Garcia, M L
Gandhi, N
Granich, R M
Hollm-Delgado, M G
Holtz, T H
Iseman, M D
Jarlsberg, L G
Keshavjee, S
Kim, H-R
Koh, W-J
Lancaster, J
Lange, C
de Lange, W C M
Leimane, V
Leung, C C
Li, J
Menzies, D
Migliori, G B
Mishustin, S P
Mitnick, C D
Narita, M
O'Riordan, P
Pai, M
Palmero, D
Park, S-k
Pasvol, G
Peña, J
Pérez-Guzmán, C
Quelapio, M I D
Ponce-de-Leon, A
Riekstina, V
Robert, J
Royce, S
Schaaf, H S
Seung, K J
Shah, L
Shim, T S
Shin, S S
Shiraishi, Y
Sifuentes-Osornio, J
Sotgiu, G
Strand, M J
Tabarsi, P
Tupasi, T E
van Altena, R
Van der Walt, M
Van der Werf, T S
Vargas, M H
Viiklepp, P
Westenhouse, J
Yew, W W
Yim, J-J
Affiliation
Bureau of Tuberculosis, New York, New York, United States of America.Issue Date
2012-08
Metadata
Show full item recordJournal
PLoS MedicineAbstract
Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual patient data meta-analysis to assess the impact on outcomes of the type, number, and duration of drugs used to treat MDR-TB.PubMed ID
22952439Language
enISSN
1549-1676ae974a485f413a2113503eed53cd6c53
10.1371/journal.pmed.1001300
Scopus Count
Collections
Related articles
- Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
- Authors: Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry P, Becerra M, Chan ED, Chan PC, Ioana Chiotan D, Crossa A, Drobac PC, Fairlie L, Falzon D, Flood J, Gegia M, Hicks RM, Isaakidis P, Kadri SM, Kampmann B, Madhi SA, Marais E, Mariandyshev A, Méndez-Echevarría A, Moore BK, Nargiza P, Ozere I, Padayatchi N, Ur-Rehman S, Rybak N, Santiago-Garcia B, Shah NS, Sharma S, Shim TS, Skrahina A, Soriano-Arandes A, van den Boom M, van der Werf MJ, van der Werf TS, Williams B, Yablokova E, Yim JJ, Furin J, Hesseling AC, Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR-TB.
- Issue date: 2018 Jul
- Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
- Authors: Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017., Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M, Menzies D
- Issue date: 2018 Sep 8
- Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
- Authors: Parmar MM, Sachdeva KS, Dewan PK, Rade K, Nair SA, Pant R, Khaparde SD
- Issue date: 2018
- Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis.
- Authors: Lee H, Ahn S, Hwang NY, Jeon K, Kwon OJ, Huh HJ, Lee NY, Kim CK, Koh WJ
- Issue date: 2018 Feb
- Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes.
- Authors: Falzon D, Gandhi N, Migliori GB, Sotgiu G, Cox HS, Holtz TH, Hollm-Delgado MG, Keshavjee S, DeRiemer K, Centis R, D'Ambrosio L, Lange CG, Bauer M, Menzies D, Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB.
- Issue date: 2013 Jul